Welcome to our dedicated page for UNIVERSAL HEALTH SERVICES SEC filings (Ticker: UHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNIVERSAL HEALTH SERVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNIVERSAL HEALTH SERVICES's regulatory disclosures and financial reporting.
Universal Health Services (UHS) reported an insider equity transaction by Executive Vice President Matthew J. Peterson. On 10/29/2025, he exercised options for 8,425 Class B shares at $138.8 and 9,465 shares at $152.68 (transaction code M), converting derivatives into common stock.
To satisfy tax obligations, 14,312 shares were withheld at $225.15 (code F). Following these transactions, he directly owned 19,957.5817 Class B shares. The options exercised had vested ratably on 3/17/2022, 3/17/2023, 3/17/2024, and 3/17/2025, and 0 derivative securities remained after the transactions. Holdings include 583.5817 shares acquired through the company’s 2005 Employee Stock Purchase Plan.
Universal Health Services (UHS) director Elliot J. Sussman, M.D., reported insider transactions. On 10/29/2025, he exercised 2,500 options at $138.80 per share (code M), satisfied taxes through the withholding of 1,535 shares at $226.15 (code F), and sold 965 shares at a weighted average price of $225.6981 (code S).
Following these transactions, his directly held Class B common shares were 6,113. The sale price reflects multiple trades between $225.38 and $225.80 as disclosed.
Universal Health Services (UHS) reported insider transactions by President and CEO Marc D. Miller. On 10/29/2025, he exercised options for 75,000 Class B shares at $138.8 and 90,000 Class B shares at $152.68 (code M). Shares totaling 131,758 were withheld to cover taxes at $225.3 (code F).
After these transactions, Miller directly owned 311,296 Class B shares. He also reported indirect holdings through several family trusts, including stakes in the Abby Danielle Miller 2002 Trust, Abby Miller King 2011 Family Trust, Marc Daniel Miller 2002 and 2011 Family Trusts, and Marni Spencer 2002 and 2011 Family Trusts.
Universal Health Services (UHS) reported insider activity by Executive Chairman, Director and 10% Owner Alan B. Miller. On 10/29/2025, he exercised options (code M) to acquire 70,213 Class B shares at $152.68 and 62,500 Class B shares at $138.8. He also disposed of 105,519 Class B shares (code F) at $227.04.
Following these transactions, Miller directly owned 1,746,031 Class B shares. The filing also lists indirect holdings across several entities, including 55,763 shares by The Abby Miller King 2011 Family Trust and 59,900 shares by The Marc Daniel Miller 2011 Family Trust. The options referenced carry an expiration date of 03/16/2026. The report notes a disclaimer of beneficial ownership for certain indirect holdings.
Universal Health Services (UHS) filed a Form 144 notice for a proposed sale of up to 965 shares of common stock with an aggregate market value of $217,798.67. The filing lists Morgan Stanley Smith Barney LLC as broker and the NYSE as the exchange, with an approximate sale date of 10/29/2025.
The securities were acquired via a stock option exercise paid in cash on 10/29/2025. Shares outstanding were 63,638,690.
Universal Health Services (UHS) furnished an Item 2.02 update, stating it issued a press release on October 27, 2025 regarding results of operations and financial condition. The release is attached as Exhibit 99.1.
The filing also lists the Cover Page Interactive Data File as Exhibit 104 and confirms UHS’s Class B common stock trades on the NYSE under the symbol UHS.
Universal Health Services, Inc. reports that its wholly owned administrative services subsidiary, UHS of Delaware, Inc., has received an adverse jury verdict in a Nevada lawsuit related to physician departures from St. Mary’s Medical Group in Reno to Pinnacle Medical Group.
The jury awarded approximately $4.7 million in compensatory damages against UHS of Delaware, Inc. and other defendants, and $500 million in punitive damages against UHS of Delaware, Inc., with lesser punitive amounts against some other defendants. The company states that, based on Nevada statutory law, it expects the punitive damages to be reduced to a maximum of approximately $14 million, and notes that recent Nevada Supreme Court precedent could further reduce the punitive amount.
UHS of Delaware, Inc. and the other defendants are evaluating legal options and intend to challenge the verdict in post-judgment proceedings and on appeal. The company states it is uncertain about its ultimate financial exposure and warns that if it cannot reverse the verdict, significantly reduce damages, or if it must post a substantial bond pending appeal, the matter could have a material adverse effect on its financial condition.
Universal Health Services reported stronger operating results for the quarter and first half of 2025. Net revenues for the three months ended June 30, 2025 were $4.284 billion versus $3.908 billion a year earlier, and net income attributable to UHS was $353.2 million versus $289.2 million, producing basic EPS of $5.49 compared with $4.32 a year ago. For the six months, revenues were $8.384 billion and net income attributable to UHS was $669.9 million, with diluted EPS of $10.23 versus $8.08 in the prior year period.
The balance sheet shows total assets of $14.986 billion and total equity of $7.086 billion at June 30, 2025. Net cash provided by operating activities for the six months was $909.0 million; investing included $505.0 million of capital expenditures; financing used $319.1 million, including $378.5 million of share repurchases and $26.4 million of dividends. Self-insured reserves remain significant ($487 million professional/general liability; $147 million workers’ compensation), and the company disclosed ongoing legal matters including the Cumberland litigation and a confidential settlement that vacated a prior judgment for The Pavilion.